Follow-The-Filings

CYTK · Cytokinetics Inc.

Q3 2022 13F holders

← latest ownership dossier

Ticker
CYTK
Type
Equity
Class
COM NEW
Total reported value ($000, long equity)
Manager Report date Value Shares